The Greenbrier Companies, Inc. beats earnings expectations. Reported EPS is $1.86, expectations were $0.86. Operator: Hello, and welcome to the Greenbrier Companies Third Quarter 2025 Earnings ...

PRINCETON, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced new preclinical data on the use of Purified Cortrophin Gel ...

The Use of Purified Cortrophin® Gel in Murine Collagen-Induced Arthritis Mouse Model presented as a poster at the European Alliance of Associations for Rheumatology (EULAR) 2025 Congress PRINCETON, ...

AT&T is currently investigating a massive data breach affecting over 86 million customers, with personal data, including Social Security numbers, reportedly leaked on the dark web.

Netflix’s documentary about the catastrophe uses familiar techniques to spotlight the faulty judgment of Stockton Rush, who ran OceanGate.

Data featured in oral presentation and poster session at 48th European Cystic Fibrosis Conference WALTHAM, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a ...

Big data may be everywhere, but most enterprises haven’t truly unlocked its potential. Thanks to advances in accelerated computing, that’s about to change.

SAN FRANCISCO, CA, USA and SUZHOU, China I June 3, 2025 I Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes ...

The presentation will focus on Emi-Le’s Phase 1 dose escalation and backfill cohorts as of a March 8, 2025 data cut-off in patients with triple-negative breast cancer (TNBC); hormone-receptor-positive ...

During today's trading session, several stocks within the NIFTY 50 experienced notable declines, with ITC, JSW Steel, Titan Company, M&M and Hindalco feeling the most pressure.

US Stock Market Highlights: The S&P 500 eked out a modest gain on Monday (May 19) as easing Treasury yields helped investors look past Moody’s downgrade of the US credit rating. The benchmark index ...

MOUNT LAUREL, N.J. — CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for ...